APA (7th ed.) Citation

Decourt, B., Drumm-Gurnee, D., Wilson, J., Jacobson, S., Belden, C., Sirrel, S., . . . Sabbagh, M. N. (2017). Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial. Current Alzheimer research, 14(4), 403. https://doi.org/10.2174/1567205014666170117141330

Chicago Style (17th ed.) Citation

Decourt, Boris, et al. "Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial." Current Alzheimer Research 14, no. 4 (2017): 403. https://doi.org/10.2174/1567205014666170117141330.

MLA (9th ed.) Citation

Decourt, Boris, et al. "Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial." Current Alzheimer Research, vol. 14, no. 4, 2017, p. 403, https://doi.org/10.2174/1567205014666170117141330.